Cytokinetics Inc. (CYTK) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $69.92 --0%
EPS Growth %: +43.1%
Financial Fact:
Total revenues: 59.05M
Today's EPS Names:
VFS, More
EPS Growth %: +43.1%
Financial Fact:
Total revenues: 59.05M
Today's EPS Names:
VFS, More
Join SI Premium – FREE
Cytokinetics Inc. (NASDAQ: CYTK) reported Q1 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RH (RH) Tops Q2 EPS by $2.31
- Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
